CV risks vary based on menopausal hormone therapy combinations, administration methods
Cardiovascular disease risks vary depending on the type of menopausal hormone therapy combinations and administration methods used, according to a nationwide trial published in The BMJ.“Experimental studies have shown that estrogen plays a protective role in cardiovascular health by promoting angiogenesis and vasodilation, reducing cardiac fibrosis and oxidative stress and increasing high